About Virchow Biotech
Virchow Biotech is a company based in Hyderabad (India) founded in 2000. The company has 1,048 employees as of April 07, 2024. Virchow Biotech offers products and services including SCARAZE, CADEXOMER IODINE, LEUPROLIDE ACETATE, ULINASTATIN, and Bifidobacterium bifidum.
- Headquarter Hyderabad, India
- Employees 1048 as on 07 Apr, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Virchow Biotech Private Limited
- Date of Incorporation 04 Apr, 2001
- Jurisdiction \Hyderabad-55, Telangana, India
-
Annual Revenue
$68.82 M (USD)-0.86as on Mar 31, 2023
-
Net Profit
$8.58 M (USD)-20.99as on Mar 31, 2023
-
EBITDA
$16.08 M (USD)-2.63as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
1048
as on Apr 07, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Virchow Biotech
Virchow Biotech offers a comprehensive portfolio of products and services, including SCARAZE, CADEXOMER IODINE, LEUPROLIDE ACETATE, ULINASTATIN, and Bifidobacterium bifidum.
Product for wound healing and scar reduction.
Antiseptic for wound care applications.
Hormone treatment for gynecological conditions.
Protease inhibitor for urological treatments.
Probiotic strain for digestive health support.
People of Virchow Biotech
Unlock access to complete
Unlock access to complete
Funding Insights of Virchow Biotech
Detailed funding history for Virchow Biotech
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Virchow Biotech
Investment portfolio details for Virchow Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Virchow Biotech
Detailed financials for Virchow Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Virchow Biotech Comparisons
Peer comparison for Virchow Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Virchow Biotech
Detailed competitors of Virchow Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Virchow Biotech
Complete news archive for Virchow Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Virchow Biotech
Virchow Biotech was founded in 2000.
Virchow Biotech is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Ravi Kumar Gattupalli is the current CEO of Virchow Biotech.
As of Apr 07, 2024, the latest employee count at Virchow Biotech is 1,048.
Annual revenue of Virchow Biotech is $68.82M as on Mar 31, 2023.
Virchow Biotech is focussed developing biologicals and biogeneric products. It is focussed on the development of products based on recombinant DNA and molecular biology. It developed two bio-generic human therapeutics, Healace (rh PDGF-BB, marketed in India as Plermin by Dr. Reddys) and Osteotide (marketed in India as Bonista by Ranbaxy). Its product portfolio consists of 15 bio-generic products covering wound care and haemostasis, ophthalmology, orthopedics, probiotics and gastroenterology. It also has five other recombinant bio-generics in the pipeline. It is filing for US FDA approval for its developed advanced wound care products and has received Drug controls (DCGI) approval for conducting clinical trials on periogen, a recombinant therapeutic product for periodontal diseases.
Virchow Biotech offers SCARAZE, CADEXOMER IODINE, LEUPROLIDE ACETATE, ULINASTATIN, and Bifidobacterium bifidum.